SZSE:300558Pharmaceuticals
January 2025's Noteworthy Stocks Estimated Below Intrinsic Value
As we enter 2025, global markets are experiencing a mixed start to the year, with major indices showing varied performances amid economic uncertainties and profit-taking activities. Despite these fluctuations, the S&P 500 and Nasdaq Composite have completed another strong year, marking significant gains over the past two years. In this environment, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities; such stocks often possess solid...